PD-L1 Positive, EGFR-Negative, ALK-Negative Metastatic
Non-small cell lung cancer (NSCLC) encompasses a diverse group of lung malignancies, with metastatic cases requiring tailored treatment strategies. Among these, patients with PD-L1 positive,
PD-L1 positive NSCLC
PD-L1 Positive Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers and remains a leading cause of cancer-related deaths globally. A subset of